Ovarian Cancer Research Alliance
Skip to content
  • For Patients

    For Patients

    OCRA’s support and education programs are available to help you navigate your diagnosis, treatment, and life after cancer. We are here to support you and your family, offering layers of support and many ways to connect.
    Read On

    • Diagnosis and Treatment
      • Newly Diagnosed? Start Here
      • Questions About Your Cancer
      • Getting the Best Care
      • Treatment Options
      • Clinical Trials
      • Managing Side Effects
      • Recurrence
    • Living with Ovarian Cancer
      • Emotional Impact
      • Practical Matters
      • Young Adults
      • LGBTQIA+
      • How to Talk About Cancer
      • Finding Support
      • Getting Involved
      • Life After Treatment
    • Support & Education
      • Patient Information Line
      • Peer Support / Woman to Woman
      • Support Series / Staying Connected
      • National Conference
      • Webinars
      • Local Community Partner Network
      • Inspire Online Community
      • Support for Friends & Family
      • Resources
  • Research

    Research

    OCRA is the world’s largest non-government funder of ovarian cancer research and has invested more than $110 million into desperately-needed breakthroughs.
    Read On

    • Our Research
      • What We Fund
      • Scientific Advisory Committee
      • Impact & Results
      • Grantees
      • Sponsor a Scientist
      • Edmée Firth Fund for Research in Ovarian Cancer
    • For Researchers
      • Our Grant Programs
      • Apply for a Grant
      • Grant Application FAQs
    • Participate
      • Clinical Trials 101
      • Questions to Ask Your Doctor
      • Find a Clinical Trial
  • Advocacy

    Advocacy

    OCRA is the voice for the ovarian cancer community, engaging with policymakers to keep this fight a priority. Learn more about our policy positions and discover how you can take action.
    Read On

    • Our Work
      • Our Impact
      • Coalitions
      • Research Advocates
    • Our Priorities
      • Access to Care
      • Research & Education Funding
      • Patient Safety
    • Get Involved
      • Become an Advocate Leader
      • Ann Kolker Advocacy Fellowship
      • Take Action Now
      • Advocacy Days
      • STS/Teach Healthcare Students
  • How to Help

    How to Help

    The ovarian cancer community needs you— your support, your voice, your passion and commitment. There are so many ways to lend a hand, to improve the lives of thousands of patients and their families, and get us one step closer to a cure.
    Read On

    • Make a Donation
      • Donate
      • Become a Monthly Donor
      • Honor a Loved One
      • Planned Giving
      • Workplace Giving
      • Stocks & Other Financial Gifts
      • Unique Ways of Giving
    • Other Ways to Give
      • Fundraise for OCRA
      • Find a Fundraiser
      • View Events
      • Sponsor a Scientist
      • Be a Corporate Partner
      • Shop
    • Share & Volunteer
      • Talk to Your Legislators
      • Offer Peer Support
      • STS/Teach Healthcare Students
      • Join our Community Partner Network
  • News
  • About Us
  • Get the Facts
  • Need to Talk?
  • Donate
  • Like us on Facebook
  • Follow us on Instagram
  • Follow us on Twitter
  • Connect on LinkedIn
  • Connect on Inspire
  • Play our videos on YouTube
Donate
News

  • All
  • OCRA News
  • Advocacy
  • Information
  • Community
  • Research
  • Events
Page 18 of 52«‹...10...1617181920...304050...›»
Research

Phase II Trial Points to Possible Benefits of IP Chemotherapy after Neoadjuvant Therapy and Surgery

No Image Available
OCRA News

OCRFA Funded Research Identifies Mechanism Underlying Ovarian Cancer Development

No Image Available
Research

New Research Indicates that High Grade Serous Ovarian Carcinomas Originate in the Fallopian Tubes

No Image Available
Research

White Blood Cells Found in High Grade Ovarian Cancer May Point to Survival Outcomes

No Image Available
OCRA News

OCRFA Funded Study Discovers 3 Key Genes in Prevention and Treatment of BRCA1 and BRCA2 Tumors

No Image Available
Research

Adjuvant Chemotherapy Does Not Lead to Better Survival In Certain Ovarian Cancers

No Image Available
Research

Report from 2017 AACR Special Conference Addressing Critical Questions in Ovarian Cancer Research and Treatment

No Image Available
Research

Studies Show that Current Chemotherapy Dosage is Still Best Option for Epithelial Ovarian Cancer

No Image Available
Research

The Link Between Chemotherapy Resistance and a Tumor’s BRCA1/2 Mutations

No Image Available
Research

Genetic Testing Rates Found to be Low in Women With A History of Breast or Ovarian Cancer

No Image Available
Research

FDA Approves New Indication and Formulation for Olaparib

No Image Available
Research

Age When Giving Birth and Oral Contraceptives Influence One’s Risk of Ovarian Cancer

No Image Available
Page 18 of 52«‹...10...1617181920...304050...›»

Stay Informed

Get email updates about research news, action alerts and ways to join the fight.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Better Busines Bureau: Accredited Charity Charity Watch: Top Rated GuideStar Gold Transparency 2021
Ovarian Cancer Research Alliance
Headquarters
14 Pennsylvania Plaza
Suite 2110
New York, NY 10122
(212) 268-1002
Policy Office
1101 14th Street NW
Suite 850
Washington, DC 20005
(202) 331-1332
(866) 399-6262 toll-free
  • Like us on Facebook
  • Follow us on Instagram
  • Follow us on Twitter
  • Connect on LinkedIn
  • Connect on Inspire
  • Play our videos on YouTube

Make a difference today.

Donate

Terms & Privacy

© 2023 Ovarian Cancer Research Alliance, Inc. All rights reserved.